Closure Medical Corporation  
Closure Medical Corporation
News   Contact Us   Site Map   Home  
About UsHistoryMilestonesManagement Team
About Us
Our Products
Medical Professionals
Consumers
Prospective Employees
Client Login
 

About Us: Milestones

2004

January
Ethicon launches ProPen & ProPen XL products.

January
Johnson & Johnson Consumer launches BAND-AID® Brand Liquid Bandage Skin Crack Gel.


2003

January
Closure receives FDA approval to market its new High-Viscosity DERMABOND topical skin adhesive.

January
BAND-AID® Brand Liquid Bandage receives Good Housekeeping’s “Good Buy” Award.

August
Closure receives investigational device exemption to commence vascular sealant pilot study.

October
Closure medical introduces new DERMABOND delivery devices, ProPen and ProPen XL.

November
Closure initiates patient enrollment in FDA-approved pilot study for its vascular sealant product.


2002

January
FDA approves new labeling for DERMABOND adhesive to say that it acts as a barrier to microbial penetration.

April
Abbott Labs launches NEXABAND® veterinary care product line in the U.S.

April
Johnson & Johnson launches BAND-AID® Brand Liquid Bandage to retail chains in the U.S.


2001

January
FDA approves LIQUIDERM™ liquid adhesive bandage for sale in the U.S.

May
Strategic partnership with Johnson & Johnson Consumer Products Companies, Inc. is announced to market LIQUIDERM™ liquid adhesive bandage.

July
Strategic partnership with Abbott Laboratories for NEXABAND® veterinary care product line is unveiled.

December
Abbott Labs launches the NEXABAND® veterinary care product line in the United Kingdom.


2000

February
DERMABOND adhesive is cleared for market release in Japan.

December
Announcement of strategic partnership with Colgate for SOOTHE-N-SEAL® canker sore relief.


1999

September
SOOTHE-N-SEAL® canker sore relief is approved for market in the U.S. by the FDA.


1998

January
An FDA advisory panel unanimously recommends DERMABOND adhesive for approval.

August
DERMABOND adhesive is approved for market in the U.S. by the FDA.


1997

April
DERMABOND adhesive is approved for use in Europe and bears the CE mark, making it commercially available in 23 countries.


1996

September
An initial public offering (IPO) puts Closure stock on the board. Today, you can trade us as CLSR.

October
Clinical trials for DERMABOND adhesive are successfully completed.

December
The FDA gives DERMABOND adhesive “expedited processing” because of the product’s significant public health benefit.

 

 

Real People. Real Healing.